Brighton Jones LLC Raises Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Brighton Jones LLC grew its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 11.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,200 shares of the pharmacy operator’s stock after acquiring an additional 1,563 shares during the quarter. Brighton Jones LLC’s holdings in Walgreens Boots Alliance were worth $800,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of WBA. BlackRock Inc. boosted its position in shares of Walgreens Boots Alliance by 13.8% in the first quarter. BlackRock Inc. now owns 56,869,775 shares of the pharmacy operator’s stock worth $3,122,151,000 after acquiring an additional 6,907,100 shares during the last quarter. Geode Capital Management LLC grew its holdings in Walgreens Boots Alliance by 1.8% in the first quarter. Geode Capital Management LLC now owns 11,415,810 shares of the pharmacy operator’s stock valued at $624,920,000 after purchasing an additional 199,080 shares during the period. Dimensional Fund Advisors LP grew its holdings in Walgreens Boots Alliance by 3.5% in the first quarter. Dimensional Fund Advisors LP now owns 7,954,325 shares of the pharmacy operator’s stock valued at $436,535,000 after purchasing an additional 268,378 shares during the period. UBS Asset Management Americas Inc. grew its holdings in Walgreens Boots Alliance by 2.0% in the first quarter. UBS Asset Management Americas Inc. now owns 4,269,570 shares of the pharmacy operator’s stock valued at $234,399,000 after purchasing an additional 84,982 shares during the period. Finally, Swiss National Bank grew its holdings in Walgreens Boots Alliance by 5.8% in the second quarter. Swiss National Bank now owns 2,994,663 shares of the pharmacy operator’s stock valued at $157,549,000 after purchasing an additional 164,271 shares during the period. Institutional investors and hedge funds own 55.65% of the company’s stock.

WBA opened at $49.94 on Friday. The stock has a market capitalization of $43.20 billion, a PE ratio of 18.92, a P/E/G ratio of 1.41 and a beta of 0.49. The firm’s fifty day moving average price is $48.32 and its 200 day moving average price is $51.24. The company has a debt-to-equity ratio of 0.34, a current ratio of 0.77 and a quick ratio of 0.53. Walgreens Boots Alliance, Inc. has a 12-month low of $33.36 and a 12-month high of $57.05.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Wednesday, June 30th. The pharmacy operator reported $1.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.21. The firm had revenue of $34.03 billion for the quarter, compared to analysts’ expectations of $33.47 billion. Walgreens Boots Alliance had a net margin of 1.66% and a return on equity of 20.79%. The firm’s quarterly revenue was up 12.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.71 earnings per share. On average, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 4.75 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, September 10th. Shareholders of record on Friday, August 20th were paid a dividend of $0.477 per share. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.47. The ex-dividend date was Thursday, August 19th. This represents a $1.91 annualized dividend and a yield of 3.82%. Walgreens Boots Alliance’s payout ratio is presently 40.30%.

A number of equities research analysts recently issued reports on WBA shares. TheStreet downgraded shares of Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a report on Friday, June 18th. Truist Securities reduced their price target on shares of Walgreens Boots Alliance from $58.00 to $52.00 and set a “hold” rating on the stock in a research report on Friday, July 2nd. Barclays reduced their price target on shares of Walgreens Boots Alliance from $55.00 to $53.00 and set an “equal weight” rating on the stock in a research report on Tuesday, July 6th. Wolfe Research reaffirmed a “hold” rating and set a $57.00 price target on shares of Walgreens Boots Alliance in a research report on Friday, July 2nd. Finally, Robert W. Baird reaffirmed a “buy” rating and set a $68.00 price target on shares of Walgreens Boots Alliance in a research report on Friday, September 3rd. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, Walgreens Boots Alliance has an average rating of “Hold” and a consensus target price of $50.83.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services.

Recommended Story: How do buyers and sellers choose a strike price?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.